Axim Biotechnologies, Inc.

AXIM

Financials

10-QQ2 ended 06/30/2408/19/2410-Q/AQ1 ended 03/31/2405/22/2410-QQ1 ended 03/31/2405/20/2410-KFY 202304/16/2410-QQ3 ended 09/30/2311/20/23

Disclosures

8-KCurrent report10/15/248-KCurrent report03/21/248-KCurrent report02/13/248-KCurrent report12/28/238-KCurrent report06/02/23

Prospectuses and Registrations

S-1Registration statement (IPO)06/02/23S-1/ARegistration statement (amended)08/02/22S-1Registration statement (IPO)07/25/22S-8Registration of securities for employees06/14/22S-1/ARegistration statement (amended)06/09/21

Proxies

DEF 14CDefinitive information statement09/21/23PRE 14CPRE 14C08/31/23DEF 14CDefinitive information statement07/07/14PRER14CPRER14C06/16/14PRE 14CPRE 14C05/23/14

Ownership

Form 4Insider transaction10/15/24Form 4Insider transaction03/19/24Form 4Insider transaction03/19/24Form 4Insider transaction03/19/24Form 4Insider transaction03/19/24

Other

15-12GCertification of termination of registration12/06/24NT 10-QLate filing notification (10-Q)11/13/24NT 10-QLate filing notification (10-Q)08/13/24NT 10-QLate filing notification (10-Q)05/15/24NT 10-KLate filing notification (10-K)04/01/24